Table 3: Treatment Outcome., Complications and Mortality

Group N Age LDH
U/L 		Hist
Emb 		AF Valvul Creat
mmol/l 		Clinical
Results 		Technical Results Hemato
Hemorr 		Sepsis Shock Death
Surgery 13 67.9 ± 12 1900 ± 847 15% 10
(77%) 		61% 424.32 ± 150.28 5
(38.4%) 		13 (100%) 3
(23%) 		1
(7.69%) 		5
(38.4%) 		2
(15.3%)
Fibrinol 17 63.1 ± 14 1513 ± 1074 31% 12
(70%) 		56% 344.76 ± 89.28 12
(70%) 		15 (75%) 3
(17.4%) 		0 0 0
Anticoag 11 67.6 ± 15 1640 ± 640 18% 5
(45%) 		9% 335.92 ± 247.52 2
(18%) 		6 (54%) 0 5
(45.4%) 		0 4
(36.4%)

LDH : Lactate Dehydrogenase at the time of the diagnosis, Hist emb: history of confirmed episode of renal embolism or embolism at another site, AF: evidence of atrial fibrillation at the time of the diagnosis, Valvul: Known valvular disease at the time of the diagnosis, Creat: Creatinine concentration at the time of the diagnosis, Clinical results: vascularization according to DTPA, Technical results: evidence of revascularization of the arterial territory dependent on the occluded artery. Hemato: hematoma. Hemorr: Hemorrhage